This information is for authoring purpose, the correct one will be shown after click the item from the filterable view list.

XELOX

Cancer Type

Unknown Primary

Intent

Palliative

Regimen Category

Evidence-informed

Funding Program

ODB - General Benefit

Drugs Used

oxaliplatin , capecitabine

This information is for authoring purpose, the correct one will be shown after click the item from the filterable view list.

Last Updated: September 24, 2026

The information on this website is intended for informational purposes only and is not a substitute for medical advice. Always consult your health care provider if you have questions or concerns. The use of the information on this website does not create a physician-patient relationship between Ontario Health and you.
Ontario Health is committed to ensuring accessible services and communications to individuals with disabilities. To receive any information on this website in an alternate format, please contact Ontario Health’s Communications Department at: 1-877-280-8538, TTY 1-800-855-0511, or by email at info@ontariohealth.ca.